ArticleCardiovascular diabetology2026
Joint association of triglyceride-glucose (TyG) and atherogenic index of plasma (AIP) with stroke risk: findings from a nationwide prospective cohort.
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe triglyceride-glucose (TyG) index and the atherogenic index of plasma (AIP) are established surrogate markers for insulin resistance and dyslipidemia, respectively, each independently linked to stroke. However, their combined predictive value for stroke is underexplored. Consequently, this study aims to evaluate the predictive performance of the combined TyG and AIP indices for incident stroke in a middle-aged and elderly Chinese cohort.
methodsWe included 7652 adults aged ≥ 45 years without baseline stroke from the China Health and Retirement Longitudinal Study (CHARLS). TyG and AIP were calculated and dichotomized by median. The primary outcome was new-onset stroke. Cox proportional hazards models assessed associations, examining interactions on both additive (Relative Excess Risk due to Interaction, RERI) and multiplicative scales. Restricted cubic spline (RCS) analysis was used to examine nonlinear relationships. Predictive performance was assessed using area under the receiver operating characteristic curve (AUC), and model performance differences were evaluated using the DeLong test, net reclassification improvement (NRI), and integrated discrimination improvement (IDI).
resultOver 9 years, 744 strokes (9.72%) occurred. High TyG (HR = 1.41, 95% CI 1.21–1.64) and high AIP (HR = 1.44, 1.24-1.67) independently increased risk. The combination showed highest risk (HR = 1.49, 1.27-1.75). AIP had a nonlinear association (inflection ~ 0.22); TyG was linear. The combined AUC (0.633) was not significantly better (DeLong test, P > 0.05), and both NRI and IDI were non-significant. Subgroup analysis revealed stronger effects of combined indicators in aged < 60 years old and those without diabetes or heart disease history. Sensitivity analysis supported robust results. Multiplicative interaction was significant (P = 0.021), while additive interaction was non-significant (RERI = 0.280, 95% CI -0.220-0.779).
conclusionBoth the TyG index and AIP are independent risk factors for stroke. The primary value of combining these two indicators lies in identifying individuals at extremely high risk, rather than significantly enhancing overall predictive performance. This combined metric can serve as a comprehensive metabolic risk assessment tool, particularly suitable for primary stroke prevention in individuals under 60 years of age without a history of diabetes or heart disease. Future studies are needed to further validate its risk reclassification capability and intervention value.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.